LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced its participation in the Piper ...

Meeting to be held in New York on March 11 hosted by JMP Securities.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

High-rolling investors have positioned themselves bullish on Biogen BIIB, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of ...

Piper Sandler analyst Anna Andreeva says On Holding (ONON) (ON) reported a “great” Q4 with a 2025 sales growth outlook inline with the ...

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale ...

Milestone Pharmaceuticals (MIST) announced that the Company granted equity awards, in the form of a total of 94,000 options to purchase the ...

Scotiabank analyst Patrick Colville maintained a Hold rating on Okta (OKTA – Research Report) today and set a price target of $109.00. The ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on Pliant Therapeutics (PLRX – Research Report) yesterday and set a price target of ...

In a report released yesterday, Matthew Hedberg from RBC Capital maintained a Buy rating on Okta (OKTA – Research Report), with a price target ...

In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Tempus AI, Inc. Class A (TEM – Research Report) today and set a price target ...

Wells Fargo analyst Tiago Fauth maintained a Hold rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target of $3.00.